Skip to content

Released Nov 13, 2024, after the close

10-Q filed Nov 13, 2024, 44 days after period end · 0000868278-24-000014

Q3 2024 · 10-Q
Revenue$1.42M−83.1% vs Q3 2023−5.9% vs Q2 2024
Net Income-$6.59MN/M vs Q3 2023N/M vs Q2 2024
EPS Diluted-$0.35N/M vs Q3 2023N/M vs Q2 2024
Gross Profit$215,000−90.8%
Operating Income-$6,480,000N/M
Operating Cash Flowderived-$4,038,000N/M
Free Cash Flowderived-$4,037,000N/M
Margins · derived
Gross margin15.2%−12.6 pt vs Q3 2023
Operating margin-457.6%−380.2 pt vs Q3 2023
Net margin-465.2%−403.7 pt vs Q3 2023

What the release said

The release

Same quarter

MetricQ3 2024Q3 2023Q3 2022Q3 2021
Revenue$1.42M$8.37M$24.20M$9.47M
Net Income-$6.59M-$5.14M$968.00K-$3.98M
EPS Diluted-$0.35-$0.30$0.06-$0.26

The same fiscal quarter, prior years. Thaler holds no estimates to compare against.

ProPhase Labs, Inc. · CIK 868278 · Engraved from SEC EDGAR